Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luigi Lorini

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Journal of Clinical Medicine|November 26, 2022
Molecular Basis and Rationale for the Use of Targeted Agents and Immunotherapy in Sinonasal CancersAndrea Esposito, Erika Stucchi, Maria Baronchelli, et al.
Frontiers in Oncology|March 17, 2023
The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reportsElena Colombo, Cristina Gurizzan, Arianna Ottini, et al.
Oral Oncology|March 7, 2026
Curative approaches for adenoid cystic carcinoma: a multifaceted diseaseLuigi Lorini, Michele Tomasoni, Muhammad Shahid Iqbal, et al.
Oncology Reports|February 1, 2024
Evaluation of DNA methylation levels of <i>SEPT9</i> and <i>SHOX2</i> in plasma of patients with head and neck squamous cell carcinoma using droplet digital PCRIlaria Grossi, Claudia Assoni, Luigi Lorini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 16, 2025
Non-cisplatin concurrent agents plus definitive radiotherapy for locally advanced head and neck cancer: A network meta-analysis of randomized studiesFausto Petrelli, Francesca Trevisan, Massimiliano Nardone, et al.
Future Oncology (London, England)|February 29, 2024
Oncological treatment administration at end of life: a retrospective studyCristina Gurizzan, Andrea Esposito, Luigi Lorini, et al.
Scientific Reports|June 15, 2022
Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical studyTeresa Savarese, Andrea Abate, Ram Manohar Basnet, et al.
Frontiers in Oncology|June 5, 2026
Carcinoma of unknown primary (CUP) of the head and neck: state of the art and future perspectivesSara Farinatti, Alberto Paderno, Caterina Giannitto, et al.
Oral Oncology|February 12, 2021
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinomaLuigi Lorini, Laura Ardighieri, Anna Bozzola, et al.
BMC Cancer|February 18, 2025
Financial toxicity questionnaire (FIT): development and validation of the italian version (FITALY) in head and neck cancer patients undergoing multimodal curative treatmentDavide Smussi, Carlo Conti, Luigi Lorini, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Journal of Clinical Medicine|November 26, 2022
Molecular Basis and Rationale for the Use of Targeted Agents and Immunotherapy in Sinonasal CancersAndrea Esposito, Erika Stucchi, Maria Baronchelli, et al.
Frontiers in Oncology|March 17, 2023
The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reportsElena Colombo, Cristina Gurizzan, Arianna Ottini, et al.
Oral Oncology|March 7, 2026
Curative approaches for adenoid cystic carcinoma: a multifaceted diseaseLuigi Lorini, Michele Tomasoni, Muhammad Shahid Iqbal, et al.
Oncology Reports|February 1, 2024
Evaluation of DNA methylation levels of <i>SEPT9</i> and <i>SHOX2</i> in plasma of patients with head and neck squamous cell carcinoma using droplet digital PCRIlaria Grossi, Claudia Assoni, Luigi Lorini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 16, 2025
Non-cisplatin concurrent agents plus definitive radiotherapy for locally advanced head and neck cancer: A network meta-analysis of randomized studiesFausto Petrelli, Francesca Trevisan, Massimiliano Nardone, et al.
Future Oncology (London, England)|February 29, 2024
Oncological treatment administration at end of life: a retrospective studyCristina Gurizzan, Andrea Esposito, Luigi Lorini, et al.
Scientific Reports|June 15, 2022
Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical studyTeresa Savarese, Andrea Abate, Ram Manohar Basnet, et al.
Frontiers in Oncology|June 5, 2026
Carcinoma of unknown primary (CUP) of the head and neck: state of the art and future perspectivesSara Farinatti, Alberto Paderno, Caterina Giannitto, et al.
Oral Oncology|February 12, 2021
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinomaLuigi Lorini, Laura Ardighieri, Anna Bozzola, et al.
BMC Cancer|February 18, 2025
Financial toxicity questionnaire (FIT): development and validation of the italian version (FITALY) in head and neck cancer patients undergoing multimodal curative treatmentDavide Smussi, Carlo Conti, Luigi Lorini, et al.
Pageof 5